361 research outputs found
Nuclear level densities and gamma-ray strength functions in 44,45Sc
The scandium isotopes 44,45Sc have been studied with the 45Sc(3He,alpha
gamma)44Sc and 45Sc(3He,3He' gamma)45Sc reactions, respectively. The nuclear
level densities and gamma-ray strength functions have been extracted using the
Oslo method. The experimental level densities are compared to calculated level
densities obtained from a microscopic model based on BCS quasiparticles within
the Nilsson level scheme. This model also gives information about the parity
distribution and the number of broken Cooper pairs as a function of excitation
energy. The experimental gamma-ray strength functions are compared to
theoretical models of the E1, M1, and E2 strength, and to data from (gamma,n)
and (gamma,p) experiments. The strength functions show an enhancement at low
gamma energies that cannot be explained by the present, standard models.Comment: 21 pages, 13 figures. Published versio
Microcanonical entropies and radiative strength functions of V
The level densities and radiative strength functions (RSFs) of V
have been extracted using the (He,) and
(He,He) reactions, respectively. From the level
densities, microcanonical entropies are deduced. The high -energy part
of the RSF is described by the giant electric dipole resonance. A significant
enhancement over the predicted strength in the region of MeV is seen, which at present has no theoretical explanation.Comment: 16 pages including 9 figure
Screening of patients with tuberculosis for diabetes mellitus in China.
Objectiveâ There is a high burden of both diabetes (DM) and tuberculosis (TB) in China, and this study aimed to assess feasibility and results of screening patients with TB for DM within the routine healthcare setting of six health facilities. Methodâ Agreement on how to screen, monitor and record was reached in May 2011 at a stakeholders' meeting, and training was carried out for staff in the six facilities in July 2011. Implementation started in September 2011, and we report on 7âmonths of activities up to 31 March 2012. Resultsâ There were 8886 registered patients with TB. They were first asked whether they had DM. If the answer was no, they were screened with a random blood glucose (RBG) followed by fasting blood glucose (FBG) in those with RBGââ„â6.1âmm (one facility) or with an initial FBG (five facilities). Those with FBGââ„â7.0âmm were referred to DM clinics for diagnostic confirmation with a second FBG. Altogether, 1090 (12.4%) patients with DM were identified, of whom 863 (9.7%) had a known diagnosis of DM. Of 8023 patients who needed screening for DM, 7947 (99%) were screened. This resulted in a new diagnosis of DM in 227 patients (2.9% of screened patients), and of these, 226 were enrolled to DM care. In addition, 575 (7.8%) persons had impaired fasting glucose (FBG 6.1 to <7.0âmm). Prevalence of DM was significantly higher in patients in health facilities serving urban populations (14.0%) than rural populations (10.6%) and higher in hospital patients (13.5%) than those attending TB clinics (8.5%). Conclusionâ This pilot project shows that it is feasible to screen patients with TB for DM in the routine setting, resulting in a high yield of patients with known and newly diagnosed disease. Free blood tests for glucose measurement and integration of TB and DM services may improve the diagnosis and management of dually affected patients
Extraction of thermal and electromagnetic properties in 45Ti
The level density and gamma-ray strength function of 45Ti have been
determined by use of the Oslo method. The particle-gamma coincidences from the
46Ti(p,d gamma)45Ti pick-up reaction with 32 MeV protons are utilized to obtain
gamma-ray spectra as function of excitation energy. The extracted level density
and strength function are compared with models, which are found to describe
these quantities satisfactorily. The data do not reveal any single-particle
energy gaps of the underlying doubly magic 40Ca core, probably due to the
strong quadruple deformation
Modelling the impact of social protection on tuberculosis: the S-PROTECT project.
BACKGROUND: Tackling the social determinants of Tuberculosis (TB) through social protection is a key element of the post-2015 End TB Strategy. However, evidence informing policies are still scarce. Mathematical modelling has the potential to contribute to fill this knowledge gap, but existing models are inadequate. The S-PROTECT consortium aimed to develop an innovative mathematical modelling approach to better understand the role of social protection to improve TB care, prevention and control. METHODS: S-PROTECT used a three-steps approach: 1) the development of a conceptual framework; 2) the extraction from this framework of three high-priority mechanistic pathways amenable for modelling; 3) the development of a revised version of a standard TB transmission model able to capture the structure of these pathways. As a test case we used the Bolsa Familia Programme (BFP), the Brazilian conditional cash transfer scheme. RESULTS: Assessing one of these pathways, we estimated that BFP can reduce TB prevalence by 4% by improving households income and thus their nutritional status. When looking at the direct impact via malnutrition (not income mediated) the impact was 33%. This variation was due to limited data availability, uncertainties on data transformation and the pathway approach taken. These results are preliminary and only aim to serve as illustrative example of the methodological challenges encountered in this first modelling attempt, nonetheless they suggest the potential added value of integrating TB standard of care with social protection strategies. CONCLUSIONS: Results are to be confirmed with further analysis. However, by developing a generalizable modelling framework, S-PROTECT proved that the modelling of social protection is complex, but doable and allowed to draw the research road map for the future in this field
Economic Support to Patients in HIV and TB Grants in Rounds 7 and 10 from the Global Fund to Fight AIDS, Tuberculosis and Malaria.
People with TB and/or HIV frequently experience severe economic barriers to health care, including out-of-pocket expenses related to diagnosis and treatment, as well as indirect costs due to loss of income. These barriers can both aggravate economic hardship and prevent or delay diagnosis, treatment and successful outcome, leading to increased transmission, morbidity and mortality. WHO, UNAIDS and the ILO argue that economic support of various kinds is essential to enable vulnerable people to protect themselves from infection, avoid delayed diagnosis and treatment, overcome barriers to adherence, and avert destitution. This paper analyses successful country proposals to the Global Fund to Fight AIDS, Tuberculosis and Malaria that include economic support in Rounds 7 and 10; 36 and 20 HIV and TB grants in Round 7 and 32 and 26, respectively, in Round 10. Of these, up to 84 percent included direct or indirect economic support for beneficiaries, although the amount constituted a very small proportion of the total grant. In TB grants, the objectives of economic support were generally clearly stated, and focused on mechanisms to improve treatment uptake and adherence, and the case was most clearly made for MDR-TB patients. In HIV grants, the objectives were much broader in scope, including mitigation of adverse economic and social effects of HIV and its treatment on both patients and families. The analysis shows that economic support is on the radar for countries developing Global Fund proposals, and a wide range of economic support activities are in place. In order to move forward in this area, the wealth of country experience that exists needs to be collated, assessed and disseminated. In addition to trials, operational research and programme evaluations, more precise guidance to countries is needed to inform evidence-based decision about activities that are cost-effective, affordable and feasible
ELM triggering conditions for the integrated modeling of H-mode plasmas
Recent advances in the integrated modeling of ELMy H-mode plasmas are
presented. A model for the H-mode pedestal and for the triggering of ELMs
predicts the height, width, and shape of the H-mode pedestal and the frequency
and width of ELMs. Formation of the pedestal and the L-H transition is the
direct result of ExB flow shear suppression of anomalous transport. The
periodic ELM crashes are triggered by either the ballooning or peeling MHD
instabilities. The BALOO, DCON, and ELITE ideal MHD stability codes are used to
derive a new parametric expression for the peeling-ballooning threshold. The
new dependence for the peeling-ballooning threshold is implemented in the ASTRA
transport code. Results of integrated modeling of DIII-D like discharges are
presented and compared with experimental observations. The results from the
ideal MHD stability codes are compared with results from the resistive MHD
stability code NIMROD.Comment: 12th International Congress on Plasma Physics, 25-29 October 2004,
Nice (France
Crossing the Dripline to 11N Using Elastic Resonance Scattering
The level structure of the unbound nucleus 11N has been studied by 10C+p
elastic resonance scattering in inverse geometry with the LISE3 spectrometer at
GANIL, using a 10C beam with an energy of 9.0 MeV/u. An additional measurement
was done at the A1200 spectrometer at MSU. The excitation function above the
10C+p threshold has been determined up to 5 MeV. A potential-model analysis
revealed three resonance states at energies 1.27 (+0.18-0.05) MeV (Gamma=1.44
+-0.2 MeV), 2.01(+0.15-0.05) MeV, (Gamma=0.84 +-$0.2 MeV) and 3.75(+-0.05) MeV,
(Gamma=0.60 +-0.05 MeV) with the spin-parity assignments I(pi) =1/2+, 1/2- and
5/2+, respectively. Hence, 11N is shown to have a ground state parity inversion
completely analogous to its mirror partner, 11Be. A narrow resonance in the
excitation function at 4.33 (+-0.05) MeV was also observed and assigned
spin-parity 3/2-.Comment: 14 pages, 9 figures, twocolumn Accepted for publication in PR
Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a growing concern in meeting global targets for TB control. In high-income low-TB-incidence countries, a disproportionate number of MDR-TB cases occur in migrant (foreign-born) populations, with concerns about low adherence rates in these patients compared to the host non-migrant population. Tackling MDR-TB in this context may, therefore, require unique approaches. We conducted a systematic review and meta-analysis to identify and synthesise data on MDR-TB treatment adherence in migrant patients to inform evidence-based strategies to improve care pathways and health outcomes in this group. METHODS: This systematic review and meta-analysis was conducted in line with PRISMA guidelines (PROSPERO 42017070756). The databases Embase, MEDLINE, Global Health and PubMed were searched to 24 May 2017 for primary research reporting MDR-TB treatment adherence and outcomes in migrant populations, with no restrictions on dates or language. A meta-analysis was conducted using random-effects models. RESULTS: From 413 papers identified in the database search, 15 studies reporting on MDR-TB treatment outcomes for 258 migrants and 174 non-migrants were included in the systematic review and meta-analysis. The estimated rate of adherence to MDR-TB treatment across migrant patients was 71% [95% confidence interval (CI)â=â58-84%], with non-adherence reported among 20% (95% CIâ=â4-37%) of migrant patients. A key finding was that there were no differences in estimated rates of adherence [risk ratio (RR)â=â1.05; 95% CIâ=â0.82-1.34] or non-adherence (RRâ=â0.97; 95% CIâ=â0.79-1.36) between migrants and non-migrants. CONCLUSIONS: MDR-TB treatment adherence rates among migrants in high-income low-TB-incidence countries are approaching global targets for treatment success (75%), and are comparable to rates in non-migrants. The findings highlight that only just over 70% of migrant and non-migrant patients adhere to MDR-TB treatment. The results point to the importance of increasing adherence in all patient groups, including migrants, with an emphasis on tailoring care based on social risk factors for poor adherence. We believe that MDR-TB treatment targets are not ambitious enough
- âŠ